A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)

Clinical trial NCT07700238 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07700238
Sponsor: Amgen
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Immune Thrombocytopenia

Start date: 2026-07-20
Primary completion: 2029-09-14
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.